Cytek Biosciences, Inc. (CTKB)
5.59
+0.16
(+2.95%)
USD |
NASDAQ |
Oct 23, 16:00
5.59
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Profit Margin (Quarterly) : -25.26% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.26% |
| March 31, 2026 | -42.75% |
| December 31, 2025 | -70.93% |
| September 30, 2025 | -10.48% |
| June 30, 2025 | -12.24% |
| March 31, 2025 | -27.50% |
| December 31, 2024 | 16.78% |
| September 30, 2024 | 1.83% |
| June 30, 2024 | -22.38% |
| March 31, 2024 | -13.75% |
| December 31, 2023 | 9.45% |
| September 30, 2023 | -13.45% |
| June 30, 2023 | -8.83% |
| Date | Value |
|---|---|
| March 31, 2023 | -18.35% |
| December 31, 2022 | 7.69% |
| September 30, 2022 | 4.02% |
| June 30, 2022 | -1.75% |
| March 31, 2022 | -6.15% |
| December 31, 2021 | 0.07% |
| September 30, 2021 | 1.01% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 1.88% |
| September 30, 2020 | 5.76% |
| June 30, 2020 | 9.93% |
| March 31, 2020 | -4.66% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 19.28% |
| Bio-Rad Laboratories, Inc. | 57.05% |
| Bruker Corp. | -6.07% |
| Danaher Corp. | 18.42% |
| Harvard Bioscience, Inc. | -12.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.06% |
| Return on Assets | -17.17% |
| Return on Invested Capital | -20.97% |
| Gross Profit Margin (Quarterly) | 58.87% |
| Operating Margin (Quarterly) | -23.68% |
| Return on Net Operating Assets | -45.00% |